FP7Реинтеграция2012–2016

BIOMEDMICROFLUIDICS · Modelling and Optimization of Microfluidic Devices for Biomedical Applications

7РП — „Хора“ (Действия „Мария Кюри“)

Период
2012-04-01 → 2016-03-31
Финансиране от ЕС
100 000 €
Участници
1
Схема
MC-CIG

Линиите свързват координатора с партньорите.

Накратко на български

Компютърни модели анализират движението и залепването на клетки (например ракови или червени кръвни клетки) в микрофлуидни устройства. Това помага да се разбере как гъстотата на кръвта влияе върху улавянето на редки ракови клетки при диагностика.

Този кратък обзор е генериран от изкуствен интелект

Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.

Резултати накратко

Modelling and Optimization of Microfluidic Devices for Biomedical Applications

Within this project we developed a computational model of biological cells flow. The model comprises important phenomena, such as fluid dynamics, fluid-structure interaction, individual cell movements, their mutual collisions. During the model development, we ensured that it is flexible enough to capture different elastic properties arising from the biology of cells (red blood cells, cancer cells) and extensible in order to include other biological or mechanical aspects. Besides the mechanical properties of the cell membrane, we developed a spring-based model of cell adhesion. In this model, the adhesion is mediated by receptor-ligand bonds that are modeled with spring-like forces. In this model, the strength of the cell adhesion can be controlled by the stiffness of the bonds. Further, the stochastic nature of bond formation is modeled by association and dissociation parameters of the model. The adhesion model mimic real behavior of cells when under the same conditions, the real cells may, or may not adhere to the surface. The accuracy of the model can be assessed by the mean and the variance of number of captured cells, when performing biological experiments with different cell lines expressing different densities of ligands. The developed model has been used for the analysis of several types of microfluidic devices. We investigated periodic obstacle arrays used for capture of rare cancer cells. We studied the influence of increased hematocrit on the trajectories of rare cells and we concluded that the probability of cell adhesion is significantly compromised when considering dense suspensions. Further we quantified how the increased hematocrit influences cell’s collision frequency in periodic obstacle arrays. We explicitly evaluated at which values of hematocrit the so called colliding mode of cell trajectories disappears. This is crucial observation because it changes optimal geometry of a periodic obstacle array when aiming at the highest probability of rare cell capture. Another types of the devices are those for gentle cell manipulation. To avoid the decrease in cell lividity and the cell damage, it is crucial to control the cell deformations during the design of microfluidic channels. We analyzed different channels and we quantified the cell damage by controlling the shape deformations. To assess the computed damage with real hemolysis, a laboratory experiment was designed for real time measurement of intracellular calcium concentration, which will be used as marker of cell activation. The computational model was implemented in an open-source scientific package ESPResSo. This step is unique, since it enables other biologists with strong background in modelling to use the model for their own purposes. Several research groups across Europe have been using this package for modelling of cell flow. This project has enabled the applicant to obtain a permanent position at the host institution. He has been successfully included in the organizational structure of the faculty as well as in the teaching process. He became an associate professor and he founded his own research group.

Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз

Цел на проекта

Circulating tumor cells (CTCs) are isolated tumor cells disseminated from the site of disease in metastatic or primary cancers, including breast, prostate, and lung cancer. CTCs can be identified and counted in the peripheral blood of patients. The biological analysis of CTCs using lab-on-chip technologies effectively diagnose the disease, determine personalized therapies, and adjust treatments in real time. This significantly increases the survival chance of the patients. Because of their rare occurrence, a few CTCs per 1 mL of blood, the CTCs must be isolated from the blood sample. Recent developments of microfluidic devices made a significant breakthrough in the detection and filtration of CTCs from blood.The aim of the project is to incorporate rigorous optimization techniques in the development of such devices. In the design process of currently manufactured devices, the focus has not been put on the performance optimization. The use of mathematically justified optimization techniques offers huge potential for increasing the efficiency.A computer tool for simulation of complex processes inside microfluidic devices will be developed. A novel capture mechanism based on local affinity interactions will be elaborated. An optimization framework will be established and implemented in the software. With this framework, new devices with higher efficiency will be designed.During the designing process, different concepts will be optimized, e.g. geometry, blood flow velocities, external magnetic fields manipulating ferromagnetic parts of the device, and other. The optimization will be carried out in a rigorous way by applying iterative optimization techniques, which is a novel element in the development of microfluidic devices.The underlying physical models will be properly calibrated and validated, and the simulation and the optimization methods will be mathematically justified.

Оригинален текст от CORDIS (на английски).

Участници

Връзки

Данни: CORDIS, © Европейски съюз